Findings from a recent study showed potential associations between psoriasis, comorbid conditions, and sexual and erectile dysfunction among patients with this skin condition.
Q. How many people in the United States have psoriasis? In what patient population is it most prevalent?
Saturday, May 28, 2016
Click here to see the answer.
Thursday, May 26, 2016
A recent study evaluated detailed drug utilization in patients with psoriasis compared with controls in a population-based sample.
Monday, May 23, 2016
The open-label extension (OLE) study evaluated the long-term safety and efficacy of etanercept (Enbrel) for pediatric psoriasis.
Friday, May 20, 2016
The Corrona Psoriasis Registry will track the drug safety reporting for ixekizumab (Taltz), a new biologic medication by Eli Lilly and Company that was recently FDA approved for the treatment of moderate to severe plaque psoriasis.